FocusPerformancePartnership

Astorg
Healthcare

Our healthcare investment approach is highly specialized and shaped by deep scientific and sector expertise. This depth helps us identify emerging opportunities, anticipate growth trends and support innovation and transformation across the healthcare ecosystem.
By partnering with international healthcare leaders, we aim to build businesses that improve the standards of care, enhance patient outcomes and create long-term value.

Shutterstock 2414239665
Shutterstock 2100441763
HEALTHCARE
~20%
Investible market

HEALTHCARE

Focused healthcare investing and creative dealmaking

Healthcare is a sector where complexity matters. Scientific progress, demographic trends and the need for more efficient healthcare systems continue to create long-term growth opportunities.

We look for international B2B leaders that provide critical products, services or technologies across the healthcare ecosystem. Our approach is shaped by scientific, regulatory and commercial understanding, supported by long-standing relationships with executives, advisors and management teams.

This depth helps us build conviction early, access differentiated opportunities, including proprietary and bilateral situations, and underwrite investment theses with clarity before ownership begins.

Healthcare sub-sectors

Where we focus

Healthcare is broad, so our focus is selective. We concentrate on three specialist subsectors, representing c.20% of the broader market, where long-term growth and resilient fundamentals create attractive opportunities.

Our expertise, networks and thematic sourcing help us identify differentiated opportunities and support global market leaders.

Pharma Services & Technology

We invest in businesses that play a critical role across the pharmaceutical value chain: from research and development, to manufacturing and commercialization.

Pharma Services & Technology

Medtech & Medtech Services

We invest in medtech businesses providing essential products or services that support patient care and clinical outcomes.

Medtech & Medtech Services

Life Science Tools & Diagnostics

We invest in businesses that support scientific research, laboratory testing and clinical decision-making.

Life Science Tools & Diagnostics
Judith Charpentier

"In healthcare, our depth of expertise - built over decades and across a focused set of subsectors - enables us to originate differentiated opportunities, partner with proven leaders and create lasting value for all stakeholders.”

Judith Charpentier

Co-Managing Partner and Head of Healthcare

Healthcare portfolio

Oxoid Remel Microbiology Logo (final, 11 08 2026)
Solabia Logo
OPEN Health Logo
Nexpring Health Logo
Nemera Logo
LGC Logo
IPL Logo
hg medical Logo
Echosens Logo
Demetra Logo
Cytel Logo
CordenPharma Logo
Avania Logo

Meet our Healthcare Team

Our Healthcare team combines investment experience, deep scientific and sector knowledge and long-standing relationships across the healthcare ecosystem. Working with executives, advisers and management teams, they help companies navigate complexity, scale internationally and create long-term value to become global healthcare leaders.

Latest Healthcare News

Solabia unveils strategic repositioning toward cosmetics and nutraceuticals
ViewMore
Healthcare
news
Solabia unveils strategic repositioning toward cosmetics and nutraceuticals
Astorg announces plans to combine Oxoid Remel Microbiology and Solabia's microbiology diagnostics division to create a leading global microbiology platform
ViewMore
Healthcare
news
Astorg announces plans to combine Oxoid Remel Microbiology and Solabia's microbiology diagnostics division to create a leading global microbiology platform
Astorg completes acquisition of Microbiology business from Thermo Fisher Scientific, establishing an independent global diagnostics specialist
ViewMore
Healthcare
news
Astorg completes acquisition of Microbiology business from Thermo Fisher Scientific, establishing an independent global diagnostics specialist
Astorg-backed CordenPharma acquires AmbioPharm, strengthening its position as a leading global peptide development and manufacturing platform
ViewMore
Healthcare
news
Astorg-backed CordenPharma acquires AmbioPharm, strengthening its position as a leading global peptide development and manufacturing platform
Astorg to acquire global microbiology business from Thermo Fisher Scientific
ViewMore
Healthcare
news
Astorg to acquire global microbiology business from Thermo Fisher Scientific
Solabia accelerates expansion plan with three strategic acquisitions
ViewMore
Healthcare
news
Solabia accelerates expansion plan with three strategic acquisitions
Solabia unveils strategic repositioning toward cosmetics and nutraceuticals
ViewMore
Healthcare
news
Solabia unveils strategic repositioning toward cosmetics and nutraceuticals
Astorg announces plans to combine Oxoid Remel Microbiology and Solabia's microbiology diagnostics division to create a leading global microbiology platform
ViewMore
Healthcare
news
Astorg announces plans to combine Oxoid Remel Microbiology and Solabia's microbiology diagnostics division to create a leading global microbiology platform
Astorg completes acquisition of Microbiology business from Thermo Fisher Scientific, establishing an independent global diagnostics specialist
ViewMore
Healthcare
news
Astorg completes acquisition of Microbiology business from Thermo Fisher Scientific, establishing an independent global diagnostics specialist
Astorg-backed CordenPharma acquires AmbioPharm, strengthening its position as a leading global peptide development and manufacturing platform
ViewMore
Healthcare
news
Astorg-backed CordenPharma acquires AmbioPharm, strengthening its position as a leading global peptide development and manufacturing platform
Astorg to acquire global microbiology business from Thermo Fisher Scientific
ViewMore
Healthcare
news
Astorg to acquire global microbiology business from Thermo Fisher Scientific
Solabia accelerates expansion plan with three strategic acquisitions
ViewMore
Healthcare
news
Solabia accelerates expansion plan with three strategic acquisitions

Related insights from Astorg hub

Nemera: Designing around the patient
WatchVideo
Portfolio Voices
video
Nemera: Designing around the patient
Jun 1, 2026